Connect with us

Press Releases

Aurion Biotech Appoints Jonathan Sparks as Chief Legal Officer

Deep expertise in intellectual property to support company’s innovations.




(PRESS RELEASE) SEATTLE, BOSTON AND TOKYO — Aurion Biotech, whose mission is to restore vision to millions of patients with its life-changing regenerative therapies, announced it has appointed Dr. Jonathan Sparks as chief legal officer. Dr. Sparks will lead the company’s global legal affairs team.

“We are delighted to welcome Jon to Aurion Biotech,” said Greg Kunst, chief executive officer. “In addition to his deep expertise in intellectual property and legal affairs, Jon has a wealth of general management experience with emerging biotech companies, which will benefit us enormously as we enter into our next phase of innovation and growth.”

In addition to his role at Aurion, Dr. Jonathan Sparks is also a partner and chair of the Intellectual Property practice at McCarter & English, LLP. He has over 20 years of experience as a legal professional representing life science companies, both as outside counsel and as an executive at companies. In his private practice, Dr. Sparks counsels clients on general intellectual property matters, including patent prosecution, domestic and foreign patent strategy, due diligence, and patent lifecycle management. He also has extensive experience with patentability, infringement, validity, and freedom-to-operate analysis. Dr. Sparks has previously served as general counsel, chief Intellectual property counsel and chief compliance officer for Ocular Therapeutix, Inc., and general counsel for Applied Genetic Technologies Corporation.

Prior to starting his legal career, Dr. Sparks conducted research in the areas of physical biochemistry and molecular biology while obtaining his PhD at Texas A&M University. In addition to his PhD, Dr. Sparks holds a JD from Suffolk University Law School and a BA in Biochemistry from Ithaca College.

Dr. Sparks is a member of the Massachusetts Bar, the US Patent & Trademark Office, the American Intellectual Property Law Association, the Boston Patent Law Association and the Boston Bar Association.




The Best Overall Progressive Lens, Now Powered by AI

Engineered with Behavioral Artificial Intelligence and utilizing new XR-motion™ technology, Varilux XR series goes beyond prescription and eye physiology to consider the patient’s visual behavior and design a progressive lens that respects how
their eyes naturally move.

Varilux XR series comes in two versions, Varilux® XR design and Varilux® XR track. The Varilux XR track lens provides an additional level of personalization by incorporating the exclusive Near Vision Behavior Measurement, providing up to 25% more near vision width3 according to the patient’s need, so patients get the highest level of customization.

Discover Varilux XR series and enjoy instantly sharp vision in motion4 and seamless transitions from near to far.

For more information, visit here.

Promoted Headlines





Get the most important news and business ideas for eyecare professionals every weekday from INVISION.



Most Popular